Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5583122 | WARNER CHILCOTT | Pharmaceutical compositions containing geminal diphosphonates |
Dec, 2013
(10 years ago) | |
US5583122 (Pediatric) | WARNER CHILCOTT | Pharmaceutical compositions containing geminal diphosphonates |
Jun, 2014
(9 years ago) | |
US6165513 | WARNER CHILCOTT | Film-coated tablet for improved upper gastrointestinal tract safety |
Jun, 2018
(5 years ago) | |
US5994329 | WARNER CHILCOTT | Method for inhibiting bone resorption |
Jul, 2018
(5 years ago) | |
US6432932 | WARNER CHILCOTT | Method for inhibiting bone resorption |
Jul, 2018
(5 years ago) | |
US6015801 | WARNER CHILCOTT | Method for inhibiting bone resorption |
Jul, 2018
(5 years ago) | |
US6465443 | WARNER CHILCOTT | Method for inhibiting bone resorption |
Aug, 2018
(5 years ago) | |
US6165513 (Pediatric) | WARNER CHILCOTT | Film-coated tablet for improved upper gastrointestinal tract safety |
Dec, 2018
(5 years ago) | |
US6432932 (Pediatric) | WARNER CHILCOTT | Method for inhibiting bone resorption |
Jan, 2019
(5 years ago) | |
US5994329 (Pediatric) | WARNER CHILCOTT | Method for inhibiting bone resorption |
Jan, 2019
(5 years ago) | |
US6015801 (Pediatric) | WARNER CHILCOTT | Method for inhibiting bone resorption |
Jan, 2019
(5 years ago) | |
US6465443 (Pediatric) | WARNER CHILCOTT | Method for inhibiting bone resorption |
Feb, 2019
(5 years ago) |
Drugs and Companies using CALCIUM CARBONATE; RISEDRONATE SODIUM ingredient
Market Authorisation Date: 12 August, 2005
Treatment: Prevention and treatment of osteoporosis; 35 mg orally once a week for prevention of osteoporosis in postmenopausal women; 35 mg orally once a week for treatment of osteoporosis in postmenopausal wome...
Dosage: TABLET;ORAL